OmniAb
clinical and approved partner pipeline two products derived antibodies | OmniAb
Company
Deck Type
Sector
Industry
Deck date
March 2022
Slide
24 of 35
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical patient population large and diagnosable no approved medical therapy disease overview cerebral cavernous malformations | Recursion Pharmaceuticals
Adagio Therapeutics
Investor Conference
January 2022
in neutralization of antibodies in clinical development versus variants of concern | Adagio Therapeutics
Adagio Therapeutics
Investor Conference
January 2022
in neutralization of antibodies in clinical development versus variants of concern | Adagio Therapeutics
Dare Bioscience
Investor Presentation
July 2023
advancing products women want the portfolio snapshot | Dare Bioscience
Other recent decks by OmniAb
See all presentations (10 decks)
Results
November 2024
Results
March 2024
Results
August 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io